Metriopharm
  • en
  • de
MetrioPharm AG
  • Home
  • About us
    • Our Company
    • Management and Board
    • Career
  • Technology
    • MetrioPharm Platform
    • Mechanism of Action
    • Scientific Publications
  • Pipeline
    • Indications
    • Patent Protection
  • Investors
    • IR-News
    • Financial Reports and Downloads
    • Annual General Meeting
  • Press
    • Press Releases
    • Corporate Calendar
  • Contact
    • Contact form
    • Privacy policy
    • Imprint
  • en
  • de
  1. Home
  2. About us
  3. Sitemap

Sitemap

Get a quick overview:
We provide you a sitemap, which shows the structure of our website in a simple form.

 
  • Home
  • About us
    • Our Company
    • Management and Board
    • Career
  • Technology
    • MetrioPharm Platform
    • Mechanism of Action
    • Scientific Publications
  • Pipeline
    • Indications
    • Patent Protection
  • Investors
    • IR-News
    • Financial Reports and Downloads
    • Annual General Meeting
  • Press
    • Press Releases
    • Corporate Calendar
  • Contact
    • Contact form
    • Privacy policy
    • Imprint
 

News

MetrioPharm Receives Orphan Drug Designation for the Treatment of Duchenne Muscular Dystrophy - 2023-May-30

FDA grants orphan drug designation for MetrioPharm's lead compound MP1032 for the treatment of Duchenne muscular dystrophy (DMD).

» more

Investor Relations

Investor Relations News QI 2023 - 2023-Mar-30

Invitation to a Webinar, Company Calendar, MetrioPharm informs

» more

Blog

Read our latest blog post: - 2021-May-12

Phase II Clinical Trial in COVID-19

» more

Navigation

  • Home
  • About us
  • Technology
  • Pipeline
  • Investors
  • Press
  • Contact

Social

        

Newsletter

Subscribe to our press releases with the
MetrioPharm PR newsletter

Investors can subscribe to our quaterly corporate information with the
MetrioPharm IR newsletter

Switzerland (HQ)

MetrioPharm AG

Europaallee 41
8004 Zurich

Phone: +41 44 552 7190

Germany (R&D)

MetrioPharm Deutschland GmbH

Am Borsigturm 100
13507 Berlin

Phone: +49 30 3384 395 02

  • © 2023 MetrioPharm AG
  • Imprint
  • Privacy policy (We don’t collect cookies)
  • Sitemap